chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shortly after booster, began experiencing nephrotic issues that substantially worsened from my previous problems with minor protein urea. Caught at routine checkup with nephrologist for 6 month checkup on 11/10/22. Did a 24 hr urine test, went from 300 grams of proteins before, to 4000 grams of protein. Irbestartin increase because blood pressure was very high. That did not help, so they gave me chlorthalidone 12.5 mg as well. This has not helped much either. The doctor and I concluded that the treatment would require strong streoids, but we are currently holding off to see if this will resolve itself after the vaccine reaction dies down. I have a follow up on April 1st. Still experiencing issues
Large nodule right deltoid - 8 days later after getting vaccine Scattered macular rash right arm - 8 days later Body aches -10 days later  Advised ice to site and Benadryl 50 mg every 6 hours on 1/20/21 Spoke to patient via phone, rash slightly better and lump smaller but felt worse with body aches, chills. Prescribed Azithromycin 250 mg  for 5 days.
pt. rcvd 3rd dose of hepatitis B vac. & exp. aches,chills,nausea,diarrhea & pain in arm.
Patient requested Hepatitis B and Varicella Vaccine for travel purposes. Requested vaccines be administered in Right Arm, due to recent TD vaccine administered in Left Arm. Immediately after injection, patient complained of "something in throat" and was observed coughing. No swelling of tongue or lips, or respiratory distress noted. EMT was called at approximately 11:10 am and arrived at approximately at 11:20 am. EMT assessed client, BP 153/93, HR 69 BPM. EMT advised to be transported to ER, patient declined, stated her throat felt better and cough stopped.
Shortly after receiving shots had headache, neck pain, dizziness, paleness and nausea in car in parking lot. At home felt like his legs would not hold him up and seemed to hyperventilate per mom. continued to have symptoms until mid afternoon 07/24/04.
Feeling bad like he got a cold; Feeling bad like he got a cold; This is a spontaneous report from a contactable consumer. This consumer reported for 4 patients. This is 3rd of four reports. This consumer reported for a male patient (her husband's younger brother) of an unspecified age received unknown dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: Not reported), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient did feel kind of bad, feeling bad like he got a cold. Caller states that her husband's younger brother took the same vaccine the same day as her husband. She adds that the younger brother reported that he did feel kind of bad and that he went to the pharmacy and got a medication to take. Caller does not know how the younger brother is feeling or how the younger brother is doing. Caller adds that nothing was prescribed, and that the medication was over the counter. Caller does not know anything else about this. She adds that she does not know if this was a one or two days affair. The clinical outcome of both the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
About 8 pm that night, I felt my chest going really fast - my heart rate was high. I called the nurse hotline. They asked me if I had pain and I said no. Just a high heart rate. WAs told to monitor it. Next day, I had chest pain and tightness in chest and fast heartrate. I went to ER. Gave me IV; fluids and steroids. They sent me home with steroids for five days. About three or four days after steroids were done, it resolved the symptoms.
PT BECAME PALE, EYES DILATED, STIFF, COLD, CLAMMY AND FAINTED. BP 110/30,  ? ANAPHYLACTIC SHOCK. ADRENALIN .3CC (1:1000) GIVEN SUBQ -- BP 118/68 AMBULANCE CALLED. SENT TO HOSPITAL FOR OBSERVATION.  APPEARED MUCH BETTER. STILL PALE, BUT BODY TEMP INCREASED.
Intense pain at vaccination site and entire arm/neck. Next morning extreme nausea, upset stomach, exhaustion and continued pain at injection site. Very red spider web looking reaction at injection site. Pharmacist didn't tell us anything about the risks of the meningitis b vaccine and I assumed it was routine as it was on her MI required vaccination card. The pharmacist also gave her both vaccines in the same arm back to back and now I read it should have been separate arms.
This spontaneous report as received from a register nurse refers to a patient of unknown age and gender. On 21-AUG-2012, the patient was vaccinated with a dose of oral ROTATEQ Lot 0517Z that expired on 22-APR-2012. No adverse effect was reported. Additional information has been requested.
Initial report received from a health care professional on 14 October 2009. A 51-year-old female patient experienced numbness and tingling after receiving an intramuscular left deltoid injection of FLUZONE SV 2009-2010 (lot number U3195AA) on 05 October 2009. The patient was asplenic. On 11 October 2009, six days post-vaccination, she began having intermittent numbness and tingling in her arms and legs. Mobility was not effected, and the outcome was unknown. Documents held by sender: None. 10/28/09 Record received from 10/14/09. Phone consult. Pt. c/o numbness and tingling in arm for 3 days. Received flu shot on 10/5/09. Advised by pt. employee health to contact PCP. F/u call to the pt. and pt. states sx. resolved.
This case was reported by a consumer via call center representative and described the occurrence of fever in a 65-year-old male patient who received SHINGRIX for prophylaxis. On 25th July 2018 13:30, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In July 2018, less than a week after receiving SHINGRIX, the patient experienced tiredness, weakness and sleepiness. On 25th July 2018 22:00, the patient experienced fever, palpitation, sickness and chills. On 26th July 2018, the patient experienced white blood cell increased. On an unknown date, the outcome of the fever, palpitation, sickness, white blood cell increased, tiredness, weakness, sleepiness and chills were unknown. It was unknown if the reporter considered the fever, palpitation, sickness, white blood cell increased, tiredness, weakness, sleepiness and chills to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. Around 10:00 pm, 8 hours 30 minutes after receiving the first dose of the SHINGRIX vaccine in left arm, the patient felt sick and experienced fever, chills, and heart palpitations. The patient went to the emergency room at 4 am and was sent home at 8 am. The emergency room physician told him that if his fever went up again he should see his primary care physician. The patient's fever did go up that same day and he went to his primary care office and the nurse practitioner did blood work. He received the results on 30th July 2018, which showed that, patient's white blood cells were elevated (87). He said all of these symptoms resolved within 24 hours. The patient also felt weak, tired, and sleepy all of the time, which he felt was due to the vaccine.
Redness  about the size of a baseball on day 2,3&4 after second inoculation.  Pain and hot to the touch in the area.
Patient was due for the 2nd dose of Pfizer. Pfizer doses were being given in a different room. Patient received a dose of Moderna for 2nd dose instead of Pfizer.  Patient experienced no adverse effects at the time and no adverse effects as of 1/22/21 besides a sore arm. Patient was made aware of error.
On 7/30/21 during data entry it was noticed by data entry technician that the patient already had two doses of Pfizer COVID vaccine recorded in the registry, 3/31/21 and 4/21/21, both at the Vaccination Clinic.  The patient recorded "NO" to the question on the vaccine administration record 7/28/21 "Have you ever received a dose of COVID-19 vaccine."  The patient did not disclose that he had already completed his Pfizer COVID-19 vaccine series and was administered a dose of vaccine on 7/28/21 at his request.    Patient admits he did indeed had those two previous doses 3/31/21 and 4/21/21, and states "Variant's got me scared," so he decided to get a third dose having heard boosters may be recommended.  Advised that booster doses are not recommended at this time per CDC, and advised him not to get more doses unless recommended to do so by CDC guidelines.
developed red raised itchy rash on both arms as well as torso, described as an urticarial rash
Moderate arm pain; Product=COVID 19, / Brand=Pfizer, / Is bivalent=True, / Administration date=14Oct2023; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 12-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Oct2023 at 15:30 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 12 years intramuscular, in left arm for covid-19 immunisation; influenza vaccine (INFLUENZA), on 14Oct2023 as dose 1, single (Batch/Lot number: unknown), in left arm. The patient didn't receive bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)). The patient's relevant medical history included: "Migraines" (unspecified if ongoing), notes: Other medical history: Migraines. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 Immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 Immunization; Covid-19 vaccine (DOSE 3; MANUFACTURER UNKNOWN), for COVID-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 14Oct2023, outcome "not recovered", described as "Moderate arm pain"; WRONG PRODUCT ADMINISTERED (non-serious) with onset 14Oct2023, outcome "unknown", described as "Product=COVID 19, / Brand=Pfizer, / Is bivalent=True, / Administration date=14Oct2023". Therapeutic measures were not taken as a result of pain in extremity.  Additional information: The patient received his Comirnaty and Influenza vaccinations on 14Oct2023, and a few hours later on 14Oct2023 the arm pain was reported.     The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5, bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300330630 same reporter/product/events; different patient;US-PFIZER INC-202300330662 same reporter/product, different patient, with similar events;
Headache, feeling chills and hot flashes, shortness of breath, rash on face, feeling "mosquito bites" all over body
Red lengthy blotchy rash at injection site approximately 4" long and 2" wide and soreness at and near injection site
LISTLESSNESS; BODY ACHES AND PAINS; CHILLS; HEADACHE; TIREDNESS; This spontaneous report received from a patient concerned an 83 year old female. The patient's weight and height was not reported. The patient's concurrent conditions included abstains from alcohol, non smoker, and low thyroid, The patient experienced drug allergy when treated with benzylpenicillin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022, expiry: 25-MAY-2021) dose was not reported, administered on 07-MAR-2021 13:00 to Left Deltoid for prophylactic vaccination. Concomitant medications included rosuvastatin calcium for cholesterol, and levothyroxine for hypothyroid. On 08-MAR-2021, the subject experienced listlessness. On 08-MAR-2021, the subject experienced body aches and pains. On 08-MAR-2021, the subject experienced chills. On 08-MAR-2021, the subject experienced headache. On 08-MAR-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from chills, headache, body aches and pains, listlessness, and tiredness. This report was non-serious.   Version created to amend previously reported information on 08-MAR-2021. Upon review the following information was amended: Labeling of event (chills) updated to unlabeled from labeled in USPI. Labeling of event (body aches) updated to unlabeled from labeled in USPI and Core. Event ranking has been changed as per labeling corrections.  Additional information received from patient on 30-MAR-2021.The following information was updated and incorporated into the case: Reporter tab: primary reporter address added, Patient tab: date of birth, Age at the time of the event, age group, sex, height pregnancy and age at the time of vaccination added. Disease sub tab : abstain from alcohol, non smoker, low thyroid was added. Event tab: listlessness, tiredness, body ache and pains was added along with onset date and outcome as 08-MAR-2021 and recovering/ resolving. event onset date and outcome for events chills, headache, body ache and pains was changed to 08-MAR-2021 and recovering /resolving. Product tab: Concomitant drugs :Levothyroxine for hypothyroid and Crestor for cholesterol and the expiry date for suspect product was added as 25-MAY-2021. Causality was added as possible for the events listlessness, tiredness, body ache and pains. Ranking of events was changed. Seriousness criteria was changed to recovering and resolving.
Her face started swelling and turned red and her throat felt tight..  She was given .3 cc of epinephrine .  She felt better then we had to repeat the dose in about 15 more minutes.  She could still breath easily but she did not feel better after the second epinephrine shot.  She was sent to the ER in an ambulance
dizzy spells; Difficulty in walking; This is a spontaneous report based on the information received by Pfizer from Sanofi (Sanofi: 20210210000833) via a contactable consumer or other non hcp (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported, expiry date was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included teriflunomide (AUBAGIO) taken for an unspecified indication, start and stop date were not reported. On an unspecified date the patient experienced dizzy spells, difficulty in walking. Patient wanted to know if she can take her Gabapentin due to the dizzy spells. The patient was advised to contact her neurologist to see what they would like her to do. The outcome for the events was unknown.  Information about lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Itchy rash, possible hives, treated with allergy ointment and Benadryl.
Unexplained chest pain and racing heartbeat when exercising. EKG normal, waiting on CT scan to rule out blockages. 02 normal. BP normal on stress echo but high in several incidents.  Rescue inhaler did not improve shortness of breath, pain or chest tightness. Will try to update if a cause is found. No indication that this is related to vaccine but felt important to note in case other cases pop up.
Patient received both PNEUMOVAX-23 and Influenza vaccine in her left arm, upper and lower deltoid (pt requested same arm). Pt reported redness and pain in upper arm in 24hrs. In 48hrs exam showed 20cm circular warm erythematous area in the (L) deltoid with minimal pain.
On the morning of March20th, I woke up from bed later than usual -- and unable to talk well. I went into the ER and was diagnosed with Bells Palsy. The day before, I felt "funny", a bit weaker than usual and my left eye was somewhat irritated.  Nothing else was wrong with me and I had no sickness or anything notable to report that was happening with my body.  It came on suddenly.  I have complete paralysis of my left side face. And my inner ear hurts a great deal, now.  That didn't start until after 1 week.  My face is also tender to touch and slightly swollen as well.
This spontaneous report as received from a Licensed Practical Nurse refers to a 6 month old patient of unknown gender. The patient's medical history and concurrent conditions were not reported. On 17-JUN-2015, the patient (who was 6 months old) was vaccinated with a dose of VAQTA, 0.5 ml, intramuscular (drug administered to patient of inappropriate age) (lot number and expiration date were not provided). No concomitant therapies were reported, neither was any adverse experience. Additional information has been requested.
Small red, raised bumps (hives) in a 4" area just below injection site. Very itchy, slightly sore to touch. This started seven days after the injection.
Arthritic pain in joints every morning when I wake up. The worst pain is in the elbows and fingers of both arms, lesser pain and consistency in knees, ankles and toes. The doctors have all said they are aware of this potential side condition and to stretch or take anti inflammatory meds when bad.
Nausea, vomiting, headache, fatigue, malaise, sore arm, aches muscles
dry throat; arm feeling sore; This is a spontaneous report from a contactable consumer. This consumer reported similar events for two patients. This is the first of two reports.   A 43-year-old female patient received bnt162b2 (BNT162B2; lot number: EH9899), via an unspecified route of administration on 21Dec2020 at SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 21Dec2020, it was reported that she had a "weird very dry throat 3 hours after the vaccine at the same time that my arm started feeling sore." She also commented that her coworker also had a dry throat 2-3 hours after the shot and thought it was just talking to his student too much. The outcome of the event was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020510803 same reporter, suspect drug, event, different patient
Sweating; Numbness in the arm; Body aches; Throwing up; High fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), HYPOAESTHESIA (Numbness in the arm), MYALGIA (Body aches), VOMITING (Throwing up) and PYREXIA (High fever) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Sweating), HYPOAESTHESIA (Numbness in the arm), MYALGIA (Body aches), VOMITING (Throwing up) and PYREXIA (High fever). At the time of the report, HYPERHIDROSIS (Sweating), HYPOAESTHESIA (Numbness in the arm), MYALGIA (Body aches), VOMITING (Throwing up) and PYREXIA (High fever) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
This spontaneous report was received from a registered nurse, reporting on a patient of unknown gender and age. The patient's pertinent medical history included splenectomy and anxiety. Concomitant medication the patient was taking included XANAX; LEXAPRO; levothyroxine sodium; and, unspecified vitamin D. It was reported that the patient did not have any drug reactions or allergies. The nurse reported that, on 25-APR-2018, the patient experienced anxiety after being vaccinated with improperly stored PNEUMOVAX 23 injection, for prophylaxis (dose, route and anatomical site of administration were not provided. Lot number N023650; expiration date 20-MAY-2019). The reporter stated that, on the same date (reported as "after a couple of minutes"), the patient recovered from anxiety. The nurse mentioned that the patient did not look for medical attention; no treatment was administered and no any laboratory or diagnostics studies were performed to the patient. Additionally, the nurse mentioned that PNEUMOVAX 23 were exposed to a temperature excursion of 32° up to 35° (35.1°) degrees Fahrenheit (°F) during a time frame of 30 minutes; which was detected by the data logger. Previous temperature excursion was not reported. The nurse did not provide any causality assessment to anxiety in regards with PNEUMOVAX 23 administration.
Numbness in right side of face, neck and down the length of right arm. Also seeing drooping of cheek on right side of face.
I received the 2nd Pfizer booster on June 1, 2022.  About the end of June or early July 2022, my tinnitus condition worsened considerably.  The sound became very loud and continuous.  The sound of the pitch is very high and it feels like it is throughout my head instead of just in my ears.   My previous experience with tinnitus was limited to the ears and was not as loud as it is now.    The condition has not improved at all.   Some days the sound is milder but most days it is very loud and tinny.  I am retired but I feel that I could not work with the tinnitus as bad as it is now. I thought it odd that my tinnitus symptoms got much worse a few weeks after taking the 2nd COVID booster shot.
196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.; No adverse Event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse Event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse Event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.).    Concomitant medication was not provided. 196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live follow up received and added age group.
26Sep90 pt vax;  next day pt felt poor.   03Oct90 devel chest pain & dx w/ pneumonia.
had low grade fever 100.8; temp went up to 104.8 post vax adm to r/o sepsis;
body aches, fever, fatigue, weakness, chills, cough, rhinorrhea, sore throat